{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T23:09:56Z","timestamp":1792537796006,"version":"4.5.0"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Microbiol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s00203-026-04722-y","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T07:46:04Z","timestamp":1771227964000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Role of human papillomavirus (HPV) variants and host genetic susceptibility in cervical carcinogenesis"],"prefix":"10.1007","volume":"208","author":[{"given":"Ankita","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Sahani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivangi","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupama","family":"Ojha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poonam","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chakra Pani","family":"Awasthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narendra","family":"Birbiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarad Kumar","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"issue":"4","key":"4722_CR1","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00251-023-01289-3","volume":"75","author":"M Alam","year":"2023","unstructured":"Alam M, Khan NS, Rahman S (2023) Interleukin-10 gene polymorphisms and susceptibility to persistent HPV infection in Bangladeshi women. Immunogenetics 75(4):345\u2013353. https:\/\/doi.org\/10.1007\/s00251-023-01289-3","journal-title":"Immunogenetics"},{"issue":"10","key":"4722_CR2","doi-asserted-by":"publisher","first-page":"8077","DOI":"10.1007\/s00432-023-04710-5","volume":"149","author":"FAS Amin","year":"2023","unstructured":"Amin FAS, Un Naher Z, Ali PSS (2023) Molecular markers predicting the progression and prognosis of human papillomavirus-induced cervical lesions to cervical cancer. J Cancer Res Clin Oncol 149(10):8077\u20138086. https:\/\/doi.org\/10.1007\/s00432-023-04710-5","journal-title":"J Cancer Res Clin Oncol"},{"issue":"9","key":"4722_CR3","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1258\/ijsa.2008.008025","volume":"19","author":"S Asiimwe","year":"2008","unstructured":"Asiimwe S, Whalen CC, Tisch DJ, Tumwesigye E, Sethi AK (2008) Prevalence and predictors of high-risk human papillomavirus infection in a population-based sample of women in rural Uganda. Int J STD AIDS 19(9):605\u2013610. https:\/\/doi.org\/10.1258\/ijsa.2008.008025","journal-title":"Int J STD AIDS"},{"key":"4722_CR4","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1002\/jcp.26019","volume":"233","author":"A Bahrami","year":"2018","unstructured":"Bahrami A, Hasanzadeh M, Shahidsales S, Farazestanian M, Hassanian SM, Moetamani Ahmadi M, Maftouh M, Gharib M, Yousefi Z, Kadkhodayan S (2018) Genetic susceptibility in cervical cancer: from bench to bedside. J Cell Physiol 233:1929\u20131939. https:\/\/doi.org\/10.1002\/jcp.26019","journal-title":"J Cell Physiol"},{"issue":"1","key":"4722_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00262-013-1468-9","volume":"63","author":"M Baniyash","year":"2014","unstructured":"Baniyash M, Sade-Feldman M, Kanterman J (2014) Chronic inflammation and cancer: suppressing the suppressors. Cancer Immunol Immunother 63(1):11\u201320. https:\/\/doi.org\/10.1007\/s00262-013-1468-9","journal-title":"Cancer Immunol Immunother"},{"issue":"6","key":"4722_CR6","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1002\/ijc.31530","volume":"143","author":"P Basu","year":"2018","unstructured":"Basu P, Meheus F, Chami Y et al (2018) Human papillomavirus genotype distribution and cervical cancer burden in india: implications for vaccination and screening. Int J Cancer 143(6):1383\u20131393. https:\/\/doi.org\/10.1002\/ijc.31530","journal-title":"Int J Cancer"},{"issue":"1","key":"4722_CR7","first-page":"23","volume":"5","author":"AM Bedoya","year":"2012","unstructured":"Bedoya AM, Jaramillo R, Baena A (2012) Location and density of immune cells in precursor lesions and cervical cancer. Cancer Microenviron 5(1):23\u201330","journal-title":"Cancer Microenviron"},{"key":"4722_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-13-373","volume":"13","author":"E Bernard","year":"2013","unstructured":"Bernard E, Pons-Salort M, Favre M, de Sanjos\u00e9 S (2013) Comparing human papillomavirus prevalences in women with normal cytology or invasive cervical cancer to rank genotypes according to their oncogenic potential: a meta-analysis of observational studies. BMC Infect Dis 13:373. https:\/\/doi.org\/10.1186\/1471-2334-13-373","journal-title":"BMC Infect Dis"},{"issue":"2","key":"4722_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1009876","volume":"18","author":"NA Bokulich","year":"2022","unstructured":"Bokulich NA, \u0141aniewski P, Adamov A, Chase DM, Caporaso JG, Herbst-Kralovetz MM (2022) Multi-omics data integration reveals metabolome as the top predictor of the cervicovaginal microenvironment. PLoS Comput Biol 18(2):e1009876. https:\/\/doi.org\/10.1371\/journal.pcbi.1009876","journal-title":"PLoS Comput Biol"},{"issue":"2","key":"4722_CR10","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41588-024-01256-y","volume":"56","author":"P Broberg","year":"2024","unstructured":"Broberg P, Smith C, Johansson M (2024) Genome-wide association study identifies novel HLA region loci for cervical cancer risk. Nat Genet 56(2):195\u2013205. https:\/\/doi.org\/10.1038\/s41588-024-01256-y","journal-title":"Nat Genet"},{"issue":"1","key":"4722_CR11","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.vaccine.2022.10.025","volume":"41","author":"L Bruni","year":"2023","unstructured":"Bruni L, Serrano B, Alemany L (2023) Global distribution and burden of human papillomavirus genotypes in cervical cancer and precancer: updated meta-analysis and implications for prevention. Vaccine 41(1):23\u201335. https:\/\/doi.org\/10.1016\/j.vaccine.2022.10.025","journal-title":"Vaccine"},{"issue":"1","key":"4722_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/CMR.16.1.1-17.2003","volume":"16","author":"EM Burd","year":"2003","unstructured":"Burd EM (2003) Human papillomavirus and cervical cancer. Clin Microbiol Rev 16(1):1\u201317. https:\/\/doi.org\/10.1128\/CMR.16.1.1-17.2003","journal-title":"Clin Microbiol Rev"},{"issue":"5\u20136","key":"4722_CR13","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1159\/000214919","volume":"12","author":"RD Burk","year":"2009","unstructured":"Burk RD, Chen Z, Van Doorslaer K (2009) Human papillomaviruses: genetic basis of carcinogenicity. Public Health Genomics 12(5\u20136):281\u2013290. https:\/\/doi.org\/10.1159\/000214919","journal-title":"Public Health Genomics"},{"key":"4722_CR14","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.3390\/v16091357","volume":"16","author":"PE Castle","year":"2024","unstructured":"Castle PE (2024) Looking back, moving forward: challenges and opportunities for global cervical cancer prevention and control. Viruses 16:1357. https:\/\/doi.org\/10.3390\/v16091357","journal-title":"Viruses"},{"issue":"12","key":"4722_CR15","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1002\/ijc.33985","volume":"150","author":"PKS Chan","year":"2022","unstructured":"Chan PKS (2022) Prevalence and distribution of human papillomavirus genotypes in cervical cancer worldwide: a comprehensive review. Int J Cancer 150(12):2072\u20132084. https:\/\/doi.org\/10.1002\/ijc.33985","journal-title":"Int J Cancer"},{"issue":"3","key":"4722_CR16","doi-asserted-by":"publisher","first-page":"132","DOI":"10.4103\/0971-6866.92087","volume":"17","author":"K Chattopadhyay","year":"2011","unstructured":"Chattopadhyay K (2011) A comprehensive review on host genetic susceptibility to human papillomavirus infection and progression to cervical cancer. Indian J Hum Genet 17(3):132\u2013144. https:\/\/doi.org\/10.4103\/0971-6866.92087","journal-title":"Indian J Hum Genet"},{"issue":"5","key":"4722_CR17","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.00372-23","volume":"61","author":"AA Chen","year":"2023","unstructured":"Chen AA, Gheit T, Franceschi S (2023) Human papillomavirus 45 genetic variation and cervical cancer risk worldwide. J Clin Microbiol 61(5):e00372-23. https:\/\/doi.org\/10.1128\/jcm.00372-23","journal-title":"J Clin Microbiol"},{"key":"4722_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1461015","volume":"15","author":"F Chen","year":"2025","unstructured":"Chen F, Yu J, Wang CG (2025) Association between ERCC2 Lys751Gln, Asp312Asn, and Arg156Arg polymorphisms and gynecological cancer susceptibility: a meta-analysis. Front Oncol 15:1461015. https:\/\/doi.org\/10.3389\/fonc.2025.1461015","journal-title":"Front Oncol"},{"key":"4722_CR19","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.ygyno.2020.02.004","volume":"157","author":"CH Choi","year":"2020","unstructured":"Choi CH, Chung JY, Kang JH, Paik ES, Lee YY, Park W, Byeon SJ, Chung EJ, Kim BG, Hewitt SM, Bae DS (2020) Chemoradiotherapy response prediction model by proteomic expressional profiling in patients with locally advanced cervical cancer. Gynecol Oncol 157:437\u2013443. https:\/\/doi.org\/10.1016\/j.ygyno.2020.02.004","journal-title":"Gynecol Oncol"},{"key":"4722_CR20","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.pvr.2019.02.001","volume":"7","author":"GM Clifford","year":"2019","unstructured":"Clifford GM, Tenet V, Georges D, Alemany L, Pav\u00f3n MA, Chen Z, Yeager M, Cullen M, Boland JF, Bass S, Steinberg M, Raine-Bennett T, Lorey T, Wentzensen N, Walker J, Zuna R, Schiffman M, Mirabello L (2019) Human papillomavirus 16 sub-lineage dispersal and cervical cancer risk worldwide: whole viral genome sequences from 7116 HPV16-positive women. Papillomavirus Res 7:67\u201374. https:\/\/doi.org\/10.1016\/j.pvr.2019.02.001","journal-title":"Papillomavirus Res"},{"issue":"3","key":"4722_CR21","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1002\/ijc.34102","volume":"152","author":"GM Clifford","year":"2023","unstructured":"Clifford GM, Tenet V, Pirek D (2023) Human papillomavirus types in invasive cervical cancer worldwide: updated pooled analysis of HPV genotyping studies. Int J Cancer 152(3):456\u2013470. https:\/\/doi.org\/10.1002\/ijc.34102","journal-title":"Int J Cancer"},{"issue":"1","key":"4722_CR22","doi-asserted-by":"publisher","DOI":"10.3892\/br.2021.1436","volume":"45","author":"LG Da Silva","year":"2021","unstructured":"Da Silva LG, de Albuquerque BHDR, Allyrio TAMF (2021) The role of HPV-induced epigenetic changes in cervical carcinogenesis: a review. Oncol Rep 45(1):60. https:\/\/doi.org\/10.3892\/br.2021.1436","journal-title":"Oncol Rep"},{"issue":"8","key":"4722_CR23","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.31557\/APJCP.2022.23.8.2591","volume":"23","author":"KD Datkhile","year":"2022","unstructured":"Datkhile KD, More AL, Gudur RA (2022) CYP2E1 gene polymorphism and cervical cancer susceptibility in Indian women. Asian Pac J Cancer Prev 23(8):2591\u20132597. https:\/\/doi.org\/10.31557\/APJCP.2022.23.8.2591","journal-title":"Asian Pac J Cancer Prev"},{"issue":"3","key":"4722_CR24","doi-asserted-by":"publisher","first-page":"708","DOI":"10.3390\/v5030708","volume":"5","author":"F De Marco","year":"2013","unstructured":"De Marco F (2013) Oxidative stress and HPV carcinogenesis. Viruses 5(3):708\u2013731. https:\/\/doi.org\/10.3390\/v5030708","journal-title":"Viruses"},{"issue":"7","key":"4722_CR25","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/S1470-2045(22)00119-3","volume":"23","author":"S De Sanjos\u00e9","year":"2022","unstructured":"De Sanjos\u00e9 S, Alemany L, Serrano B (2022) Human papillomavirus genotype attribution in invasive cervical cancer: a worldwide analysis. Lancet Oncol 23(7):935\u2013947. https:\/\/doi.org\/10.1016\/S1470-2045(22)00119-3","journal-title":"Lancet Oncol"},{"key":"4722_CR26","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nri.2017.143","volume":"18","author":"CA Dendrou","year":"2018","unstructured":"Dendrou CA, Petersen J, Rossjohn J, Fugger L (2018) HLA variation and disease. Nat Rev Immunol 18:325\u2013339. https:\/\/doi.org\/10.1038\/nri.2017.143","journal-title":"Nat Rev Immunol"},{"issue":"17","key":"4722_CR27","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1042\/CS20160786","volume":"131","author":"SV Graham","year":"2017","unstructured":"Graham SV (2017) The human papillomavirus replication cycle and its links to cancer progression: a comprehensive review. Clin Sci Lond 131(17):2201\u20132221. https:\/\/doi.org\/10.1042\/CS20160786","journal-title":"Clin Sci Lond"},{"issue":"11","key":"4722_CR28","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/S1470-2045(12)70401-5","volume":"13","author":"P Guan","year":"2012","unstructured":"Guan P, Howell-Jones R, Li N (2012) Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer. Lancet Oncol 13(11):102\u2013112. https:\/\/doi.org\/10.1016\/S1470-2045(12)70401-5","journal-title":"Lancet Oncol"},{"issue":"2","key":"4722_CR29","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.virol.2008.11.046","volume":"384","author":"H Hausen","year":"2009","unstructured":"Hausen H (2009) Papillomaviruses in the causation of human cancers: a brief historical account. Virology 384(2):260\u2013265. https:\/\/doi.org\/10.1016\/j.virol.2008.11.046","journal-title":"Virology"},{"issue":"3","key":"4722_CR30","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.3892\/ol.2020.11754","volume":"20","author":"R Hull","year":"2020","unstructured":"Hull R, Mbele M, Makhafola T, Hicks C, Wang SM, Reis RM (2020) Cervical cancer in low- and middle-income countries. Oncol Lett 20(3):2058\u20132074. https:\/\/doi.org\/10.3892\/ol.2020.11754","journal-title":"Oncol Lett"},{"key":"4722_CR31","first-page":"1","volume":"93","author":"International Agency for Research on Cancer","year":"2010","unstructured":"International Agency for Research on Cancer (2010) IARC monographs on the evaluation of carcinogenic risks to humans. IARC Monogr Eval Carcinog Risks Hum 93:1\u2013670","journal-title":"IARC Monogr Eval Carcinog Risks Hum"},{"issue":"10","key":"4722_CR32","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1128\/JCM.01202-13","volume":"51","author":"E Jacquin","year":"2013","unstructured":"Jacquin E, Baraquin A, Ramanah R, Carcopino X, Morel A, Valmary-Degano S, Bravo IG, de Sanjos\u00e9 S, Riethmuller D, Mougin C, Pr\u00e9tet JL (2013) Methylation of human papillomavirus type 16 CpG sites at E2 binding site 1 (E2BS1), E2BS2, and the Sp1 binding site in cervical cancer samples as determined by high-resolution melting analysis PCR. J Clin Microbiol 51(10):3207\u20133215. https:\/\/doi.org\/10.1128\/JCM.01202-13","journal-title":"J Clin Microbiol"},{"issue":"3","key":"4722_CR33","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.ijgo.2003.08.017","volume":"85","author":"SH Jee","year":"2004","unstructured":"Jee SH, Won SY, Yun JE, Lee JE, Park JS, Ji SS (2004) Polymorphism p53 codon 72 and invasive cervical cancer: a meta-analysis. Int J Gynaecol Obstet 85(3):301\u2013308. https:\/\/doi.org\/10.1016\/j.ijgo.2003.08.017","journal-title":"Int J Gynaecol Obstet"},{"issue":"2","key":"4722_CR34","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.soncn.2019.02.003","volume":"35","author":"CA Johnson","year":"2019","unstructured":"Johnson CA, James D, Marzan A, Armaos M (2019) Cervical cancer: an overview of pathophysiology and management. Semin Oncol Nurs 35(2):166\u2013174. https:\/\/doi.org\/10.1016\/j.soncn.2019.02.003","journal-title":"Semin Oncol Nurs"},{"issue":"4","key":"4722_CR35","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00117-22","volume":"10","author":"A Karimi","year":"2022","unstructured":"Karimi A, Mohebbi E, McKay-Chopin S, Rashidian H, Hadji M, Peyghambari V, Zendehdel K (2022) Human papillomavirus and risk of head and neck squamous cell carcinoma in Iran. Microbiol Spectr 10(4):e00117-22. https:\/\/doi.org\/10.1128\/spectrum.00117-22","journal-title":"Microbiol Spectr"},{"issue":"3","key":"4722_CR36","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.amepre.2015.08.031","volume":"50","author":"MJ Khoury","year":"2016","unstructured":"Khoury MJ, Iademarco MF, Riley WT (2016) Precision public health for the era of precision medicine. Am J Prev Med 50(3):398\u2013401. https:\/\/doi.org\/10.1016\/j.amepre.2015.08.031","journal-title":"Am J Prev Med"},{"issue":"8","key":"4722_CR37","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/S1470-2045(09)70187-1","volume":"10","author":"SJ Klug","year":"2009","unstructured":"Klug SJ, Ressing M, Koenig J, Abba MC, Agorastos T, Brenna SM, Ciotti M, Das BR, Del Mistro A, Dybikowska A, Giuliano AR, Gudleviciene Z, Gyllensten U, Haws AL, Helland A, Herrington CS, Blettner M (2009) TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies. Lancet Oncol 10(8):772\u2013784. https:\/\/doi.org\/10.1016\/S1470-2045(09)70187-1","journal-title":"Lancet Oncol"},{"issue":"12","key":"4722_CR38","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1093\/hmg\/ddad043","volume":"32","author":"M Koel","year":"2023","unstructured":"Koel M, V\u00f5sa U, J\u00f5eloo M, L\u00e4ll K, Gualdo NP, Laivuori H (2023) GWAS meta-analyses clarify the genetics of cervical phenotypes and inform risk stratification for cervical cancer. Hum Mol Genet 32(12):2103\u20132116. https:\/\/doi.org\/10.1093\/hmg\/ddad043","journal-title":"Hum Mol Genet"},{"issue":"15","key":"4722_CR39","doi-asserted-by":"publisher","first-page":"7303","DOI":"10.1128\/JVI.02140-08","volume":"83","author":"M Lehoux","year":"2009","unstructured":"Lehoux M, D\u2019Abramo CM, Archambault J (2009) Human papillomavirus E2 protein regulates the viral life cycle by linking viral replication to the host cell cycle. J Virol 83(15):7303\u20137314. https:\/\/doi.org\/10.1128\/JVI.02140-08","journal-title":"J Virol"},{"issue":"15","key":"4722_CR40","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1001\/jama.2020.16244","volume":"324","author":"JM Lemp","year":"2020","unstructured":"Lemp JM, De Neve J, Bussmann H (2020) Lifetime prevalence of cervical cancer screening in 55 low- and middle-income countries. JAMA 324(15):1532\u20131542. https:\/\/doi.org\/10.1001\/jama.2020.16244","journal-title":"JAMA"},{"issue":"7713","key":"4722_CR41","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41586-018-0293-x","volume":"559","author":"N Li","year":"2018","unstructured":"Li N, Lam WH, Zhai Y, Cheng J, Cheng E, Zhao Y, Gao N, Tye BK (2018) Structure of the origin recognition complex bound to DNA replication origin. Nature 559(7713):217\u2013222. https:\/\/doi.org\/10.1038\/s41586-018-0293-x","journal-title":"Nature"},{"key":"4722_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1185487","volume":"13","author":"C Lin","year":"2023","unstructured":"Lin C, Zhang Y, Wang X (2023) HPV16 variant lineages and sublineages in cervical samples from Asia are associated with differential persistence and cancer risk. Front Cell Infect Microbiol 13:1185487. https:\/\/doi.org\/10.3389\/fcimb.2023.1185487","journal-title":"Front Cell Infect Microbiol"},{"key":"4722_CR43","doi-asserted-by":"publisher","DOI":"10.71373\/FEHU5094","author":"Y Lin","year":"2024","unstructured":"Lin Y, Xu XY, Liu ZY, Chen HB, Bao Y, Meng J, Li Z, An SQ, Li YQ, Hu XP, Chu JM (2024) Pan-Cancer Analysis for Identification of Tumor Antigens and Immune Subtypes in mRNA Vaccine Development. iCell. https:\/\/doi.org\/10.71373\/FEHU5094","journal-title":"iCell"},{"issue":"3","key":"4722_CR44","doi-asserted-by":"publisher","first-page":"359","DOI":"10.2217\/fon.09.8","volume":"5","author":"P Maciag","year":"2009","unstructured":"Maciag P, Sichero L, de Araujo Souza P (2009) HPV variants and HLA polymorphisms: the role of variability on the risk of cervical cancer. Future Oncol 5(3):359\u2013370. https:\/\/doi.org\/10.2217\/fon.09.8","journal-title":"Future Oncol"},{"issue":"2","key":"4722_CR45","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/ijc.29726","volume":"138","author":"K Magnus","year":"2016","unstructured":"Magnus K, Wakeham K, Sasieni P (2016) Risk prediction for cervical cancer incorporating clinical factors and genetic susceptibility variants. Int J Cancer 138(2):328\u2013336. https:\/\/doi.org\/10.1002\/ijc.29726","journal-title":"Int J Cancer"},{"issue":"7","key":"4722_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0157344","volume":"11","author":"GA Mart\u00ednez-Nava","year":"2016","unstructured":"Mart\u00ednez-Nava GA, Fern\u00e1ndez-Ni\u00f1o JA, Madrid-Marina V, Torres-Poveda K (2016) Cervical cancer genetic susceptibility: a systematic review and meta-analyses of recent evidence. PLoS One 11(7):e0157344. https:\/\/doi.org\/10.1371\/journal.pone.0157344","journal-title":"PLoS One"},{"issue":"5","key":"4722_CR47","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/eurpub\/ckaa102","volume":"30","author":"C Mattiuzzi","year":"2020","unstructured":"Mattiuzzi C, Lippi G (2020) Cancer statistics: a comparison between world health organization (WHO) and global burden of disease (GBD). Eur J Public Health 30(5):1026\u20131027. https:\/\/doi.org\/10.1093\/eurpub\/ckaa102","journal-title":"Eur J Public Health"},{"issue":"9","key":"4722_CR48","doi-asserted-by":"publisher","first-page":"4451","DOI":"10.1128\/JCM.41.9.4451-4453.2003","volume":"41","author":"P Mayaud","year":"2003","unstructured":"Mayaud P, Weiss HA, Lacey CJ, Gill DK, Mabey DC (2003) Genital human papillomavirus genotypes in Northwestern Tanzania. J Clin Microbiol 41(9):4451\u20134453. https:\/\/doi.org\/10.1128\/JCM.41.9.4451-4453.2003","journal-title":"J Clin Microbiol"},{"issue":"4","key":"4722_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006211","volume":"13","author":"AA McBride","year":"2017","unstructured":"McBride AA, Warburton A (2017) The role of integration in oncogenic progression of HPV-associated cancers. PLoS Pathog 13(4):e1006211. https:\/\/doi.org\/10.1371\/journal.ppat.1006211","journal-title":"PLoS Pathog"},{"key":"4722_CR50","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/8913860","volume":"2017","author":"AM Mehta","year":"2017","unstructured":"Mehta AM, Mooij M, Brankovi\u0107 I, Ouburg S, Morr\u00e9 SA, Jordanova ES (2017) Cervical carcinogenesis and immune response gene polymorphisms: a review. J Immunol Res 2017:8913860. https:\/\/doi.org\/10.1155\/2017\/8913860","journal-title":"J Immunol Res"},{"issue":"1","key":"4722_CR51","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1128\/JVI.00751-11","volume":"86","author":"T Mespl\u00e8de","year":"2012","unstructured":"Mespl\u00e8de T, Gagnon D, Bergeron-Labrecque F, Azar I, S\u00e9n\u00e9chal H, Coutl\u00e9e F, Archambault J (2012) P53 degradation activity, expression, and subcellular localization of E6 proteins from 29 human papillomavirus genotypes. J Virol 86(1):94\u2013107. https:\/\/doi.org\/10.1128\/JVI.00751-11","journal-title":"J Virol"},{"issue":"9","key":"4722_CR52","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djw100","volume":"108","author":"L Mirabello","year":"2016","unstructured":"Mirabello L, Yeager M, Cullen M, Boland JF, Chen Z, Wentzensen N, Zhang X, Yu K, Yang Q, Mitchell J, Roberson D, Bass S, Xiao Y, Burdett L, Raine-Bennett T, Lorey T, Castle PE, Burk RD, Schiffman M (2016) HPV16 sublineage associations with histology-specific cancer risk using HPV whole-genome sequences in 3200 women. J Natl Cancer Inst 108(9):djw100. https:\/\/doi.org\/10.1093\/jnci\/djw100","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"4722_CR53","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/cdp.1035","volume":"4","author":"B Mo","year":"2024","unstructured":"Mo B (2024) Prevalence and genotype distribution of HPV combined infections in cervical cancer screening in Lazio region, Italy. Cancer Diagn Progn 4(2):125\u2013132. https:\/\/doi.org\/10.1002\/cdp.1035","journal-title":"Cancer Diagn Progn"},{"issue":"6","key":"4722_CR54","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1056\/NEJMoa021641","volume":"348","author":"N Mu\u00f1oz","year":"2014","unstructured":"Mu\u00f1oz N, Bosch FX, de Sanjos\u00e9 S, Herrero R, Castellsagu\u00e9 X, Shah KV, Meijer CJLM (2014) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348(6):518\u2013527. https:\/\/doi.org\/10.1056\/NEJMoa021641","journal-title":"N Engl J Med"},{"key":"4722_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-023-11212-x","volume":"23","author":"LT Nguyen","year":"2023","unstructured":"Nguyen LT, Pham HQ, Tran QT (2023) Folate pathway polymorphisms (MTHFR C677T) and cervical cancer risk in Vietnamese women. BMC Cancer 23:1\u20138. https:\/\/doi.org\/10.1186\/s12885-023-11212-x","journal-title":"BMC Cancer"},{"issue":"2","key":"4722_CR56","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3390\/jpm13020161","volume":"13","author":"M Nyg\u00e5rd","year":"2023","unstructured":"Nyg\u00e5rd M, Nyg\u00e5rd S (2023) The future of cervical cancer prevention: from one-size-fits-all to personalized screening. J Pers Med 13(2):161. https:\/\/doi.org\/10.3390\/jpm13020161","journal-title":"J Pers Med"},{"key":"4722_CR57","unstructured":"O\u2019Connor M, Chan SY, Bernard HU (1995) Transcription factor binding sites in the long control region of genital HPVs. Hum Papillomaviruses Compendium III. 21\u201340"},{"issue":"11","key":"4722_CR58","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.humimm.2022.07.011","volume":"83","author":"DS Oliveira","year":"2022","unstructured":"Oliveira DS, Santos RA, Lima JF (2022) Tnf-\u03b1 promoter variants and cervical intraepithelial neoplasia progression in Brazilian patients. Hum Immunol 83(11):827\u2013835. https:\/\/doi.org\/10.1016\/j.humimm.2022.07.011","journal-title":"Hum Immunol"},{"key":"4722_CR59","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1159\/000494985","volume":"63","author":"A Paaso","year":"2019","unstructured":"Paaso A, Jaakola A, Syrj\u00e4nen S, Louvanto K (2019) From HPV infection to lesion progression: the role of HLA alleles and host immunity. Acta Cytol 63:148\u2013158. https:\/\/doi.org\/10.1159\/000494985","journal-title":"Acta Cytol"},{"issue":"1","key":"4722_CR60","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41417-023-00603-8","volume":"31","author":"Q Peng","year":"2024","unstructured":"Peng Q, Wang L, Zuo L, Gao S, Jiang X, Han Y (2024) HPV E6\/E7: mechanisms of carcinogenesis and therapeutic perspectives. Cancer Gene Ther 31(1):9\u201317. https:\/\/doi.org\/10.1038\/s41417-023-00603-8","journal-title":"Cancer Gene Ther"},{"issue":"21","key":"4722_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/ijms262110503","volume":"26","author":"JA Pineda-Migranas","year":"2025","unstructured":"Pineda-Migranas JA, Bravata-Alc\u00e1ntara JC, Cort\u00e9s-Ort\u00edz IA, Cort\u00e9s-Malag\u00f3n EM, de los \u00c1ngeles Romero-Tlalolini M, Sierra-Mart\u00ednez M, Acosta-Altamirano G (2025) Liquid biopsy biomarkers for cervical cancer: a systematic review. Int J Mol Sci 26(21):10503. https:\/\/doi.org\/10.3390\/ijms262110503","journal-title":"Int J Mol Sci"},{"issue":"6291","key":"4722_CR62","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad9926","volume":"352","author":"NJ Proudfoot","year":"2016","unstructured":"Proudfoot NJ (2016) Transcriptional termination in mammals: stopping the RNA polymerase II juggernaut. Science 352(6291):aad9926. https:\/\/doi.org\/10.1126\/science.aad9926","journal-title":"Science"},{"issue":"11","key":"4722_CR63","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.49523","volume":"15","author":"S Rathod","year":"2023","unstructured":"Rathod S, Potdar J, Gupta A, Sethi N, Dande A (2023) Empowering women\u2019s health: insights into HPV vaccination and the prevention of invasive cervical cancer. Cureus 15(11):e49523. https:\/\/doi.org\/10.7759\/cureus.49523","journal-title":"Cureus"},{"issue":"3","key":"4722_CR64","doi-asserted-by":"publisher","DOI":"10.22092\/ARI.2023.361975.2708","volume":"78","author":"H Razavi-Nikoo","year":"2023","unstructured":"Razavi-Nikoo H, Behboudi E, Aghcheli B, Hashemi SMA, Moradi A (2023) Bac to bac system efficiency for preparing HPV type 16 virus-like particle vaccine. Arch Razi Inst 78(3):997. https:\/\/doi.org\/10.22092\/ARI.2023.361975.2708","journal-title":"Arch Razi Inst"},{"issue":"1","key":"4722_CR65","doi-asserted-by":"publisher","first-page":"3","DOI":"10.31557\/APJCB.2024.9.1.3","volume":"9","author":"CM Rector","year":"2024","unstructured":"Rector CM, Raza ST, Pratap P (2024) Association of DNA repair gene polymorphisms (XRCC1 Arg399Gln) with cervical cancer susceptibility in Indian women. Asian Pac J Cancer Biol 9(1):3\u20139. https:\/\/doi.org\/10.31557\/APJCB.2024.9.1.3","journal-title":"Asian Pac J Cancer Biol"},{"key":"4722_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2025.1544220","volume":"13","author":"M Rostami Varnousfaderani","year":"2025","unstructured":"Rostami Varnousfaderani M, Khoshnazar Z, Zeratie H, Hosseini Koukamari P (2025) Optimizing HPV vaccine effectiveness: impact of vaccination age and dose schedule on immunogenicity and cervical cancer prevention. Front Public Health 13:1544220. https:\/\/doi.org\/10.3389\/fpubh.2025.1544220","journal-title":"Front Public Health"},{"key":"4722_CR67","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2014.00119","volume":"4","author":"M Safaeian","year":"2014","unstructured":"Safaeian M, Johnson LG, Yu K, Wang SS, Gravitt PE, Hansen JA, Carrington M, Schwartz SM, Gao X, Hildesheim A, Madeleine MM (2014) Human leukocyte antigen class I and II alleles and cervical adenocarcinoma. Front Oncol 4:119. https:\/\/doi.org\/10.3389\/fonc.2014.00119","journal-title":"Front Oncol"},{"issue":"11","key":"4722_CR68","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/S0140-6736(10)62235-5","volume":"11","author":"S Sanjose","year":"2010","unstructured":"Sanjose S, Quint WG, Alemany L (2010) Human papillomavirus genotype attribution in invasive cervical cancer: a worldwide population-based study. Lancet 11(11):1048\u20131056. https:\/\/doi.org\/10.1016\/S0140-6736(10)62235-5","journal-title":"Lancet"},{"issue":"8","key":"4722_CR69","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.1158\/0008-5472.CAN-09-4179","volume":"70","author":"M Schiffman","year":"2010","unstructured":"Schiffman M, Rodriguez AC, Chen Z, Wacholder S, Herrero R, Hildesheim A, Desalle R, Befano B, Yu K, Safaeian M, Sherman ME, Morales J, Guillen D, Alfaro M, Hutchinson M, Solomon D, Castle PE, Burk RD (2010) A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia. Cancer Res 70(8):3159\u20133169. https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-4179","journal-title":"Cancer Res"},{"key":"4722_CR70","unstructured":"Shanthi PB, Hareesha KS, Kudva R (2022) Automated detection and classification of cervical cancer using pap smear microscopic images: a comprehensive review and future perspectives. Eng Sci. 20\u201341"},{"key":"4722_CR71","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3389\/fonc.2024.1123154","volume":"14","author":"P Sharma","year":"2024","unstructured":"Sharma P, Gupta S, Mishra N (2024) TP53 Arg72Pro polymorphism and its association with HPV-related cervical carcinoma: a multicentric Indian study. Front Oncol 14:154\u2013162. https:\/\/doi.org\/10.3389\/fonc.2024.1123154","journal-title":"Front Oncol"},{"key":"4722_CR72","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26136016","volume":"26","author":"P Siewchaisakul","year":"2025","unstructured":"Siewchaisakul P, Fann JC-Y, Chen M-K, Hsu C-Y (2025) Genetic biomarkers associated with dynamic transitions of human papillomavirus (HPV) infection\u2013precancerous\u2013cancer of cervix for navigating precision prevention. Int J Mol Sci 26:6016. https:\/\/doi.org\/10.3390\/ijms26136016","journal-title":"Int J Mol Sci"},{"key":"4722_CR73","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26136016","volume":"26","author":"P Siewchaisakul","year":"2025","unstructured":"Siewchaisakul P, Fann JCY, Chen MK, Hsu CY (2025) Genetic biomarkers associated with dynamic transitions of human papillomavirus infection\u2013precancerous\u2013cancer of cervix for navigating precision prevention. Int J Mol Sci 26:6016. https:\/\/doi.org\/10.3390\/ijms26136016","journal-title":"Int J Mol Sci"},{"issue":"2","key":"4722_CR74","doi-asserted-by":"publisher","first-page":"e197","DOI":"10.1016\/S2214-109X","volume":"11","author":"D Singh","year":"2023","unstructured":"Singh D, Vignat J, Lorenzoni V, Eslahi M, Ginsburg O, Lauby-Secretan B, Arbyn M, Basu PS, Bray F, Vaccarella S (2023) Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO global cervical cancer elimination initiative. Lancet Glob Health 11(2):e197\u2013e206. https:\/\/doi.org\/10.1016\/S2214-109X","journal-title":"Lancet Glob Health"},{"key":"4722_CR75","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2025.1633283","volume":"16","author":"S Singh","year":"2025","unstructured":"Singh S, Singh P, Joshi T, Aftab M, Firdausi N, Khan A (2025) Human papillomavirus-mediated cervical cancer: epigenetic interplay and clinical implications. Front Microbiol 16:1633283. https:\/\/doi.org\/10.3389\/fmicb.2025.1633283","journal-title":"Front Microbiol"},{"issue":"1","key":"4722_CR76","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13027-022-00453-9","volume":"17","author":"MG Singini","year":"2022","unstructured":"Singini MG, Singh E, Bradshaw D, Chen WC, Motlhale M, Kamiza AB (2022) HPV types 16\/18 L1, E6, and E7 protein seropositivity and cervical cancer risk in HIV-positive and HIV-negative black South African women. Infect Agents Cancer 17(1):14. https:\/\/doi.org\/10.1186\/s13027-022-00453-9","journal-title":"Infect Agents Cancer"},{"issue":"8","key":"4722_CR77","doi-asserted-by":"publisher","DOI":"10.3390\/v9080248","volume":"9","author":"D Soto","year":"2017","unstructured":"Soto D, Song C, McLaughlin-Drubin ME (2017) Epigenetic alterations in human papillomavirus-associated cancers. Viruses 9(8):248. https:\/\/doi.org\/10.3390\/v9080248","journal-title":"Viruses"},{"issue":"12","key":"4722_CR78","doi-asserted-by":"publisher","first-page":"10837","DOI":"10.1007\/s11033-012-1979-z","volume":"39","author":"H Sousa","year":"2012","unstructured":"Sousa H, Santos AM, Catarino R, Pinto D, Moutinho J, Canedo P, Machado JC, Medeiros R (2012) IL-1RN VNTR polymorphism and genetic susceptibility to cervical cancer in Portugal. Mol Biol Rep 39(12):10837\u201310842. https:\/\/doi.org\/10.1007\/s11033-012-1979-z","journal-title":"Mol Biol Rep"},{"key":"4722_CR79","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1159\/000356064","volume":"45","author":"MA Stanley","year":"2014","unstructured":"Stanley MA, Sterling JC (2014) Host responses to infection with human papillomavirus. Curr Probl Dermatol 45:58\u201374. https:\/\/doi.org\/10.1159\/000356064","journal-title":"Curr Probl Dermatol"},{"issue":"5","key":"4722_CR80","doi-asserted-by":"publisher","first-page":"818","DOI":"10.2105\/AJPH.2004.060103","volume":"96","author":"SV Subramanian","year":"2006","unstructured":"Subramanian SV, Nandy S, Irving M, Gordon D, Lambert H, Davey Smith G (2006) The mortality divide in India: the differential contributions of gender, caste, and standard of living across the life course. Am J Public Health 96(5):818\u2013825. https:\/\/doi.org\/10.2105\/AJPH.2004.060103","journal-title":"Am J Public Health"},{"issue":"3","key":"4722_CR81","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"4722_CR82","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"4722_CR83","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1007\/s004399900138","volume":"105","author":"R Tachezy","year":"1999","unstructured":"Tachezy R, Mikyskov\u00e1 I, Sal\u00e1kov\u00e1 M, Van Ranst M (1999) Correlation between human papillomavirus-associated cervical cancer and p53 codon 72 arginine\/proline polymorphism. Hum Genet 105(6):564\u2013566. https:\/\/doi.org\/10.1007\/s004399900138","journal-title":"Hum Genet"},{"issue":"6","key":"4722_CR84","doi-asserted-by":"publisher","first-page":"e0129105","DOI":"10.1371\/journal.pone.0129105","volume":"10","author":"N Thakur","year":"2015","unstructured":"Thakur N, Hussain S, Nasare V et al (2015) Association of human papillomavirus infection and genetic polymorphisms with cervical cancer risk in Indian women: A systematic review and meta-analysis. PLoS ONE 10(6):e0129105. https:\/\/doi.org\/10.1371\/journal.pone.0129105","journal-title":"PLoS ONE"},{"issue":"1","key":"4722_CR85","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1.","volume":"189","author":"JM Walboomers","year":"1999","unstructured":"Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189(1):12\u201319. https:\/\/doi.org\/10.1002\/(SICI)1096-9896(199909)189:1.","journal-title":"J Pathol"},{"key":"4722_CR86","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45920-w","volume":"15","author":"JCK Wang","year":"2024","unstructured":"Wang JCK, Baddock HT, Mafi A, McLaughlin-Drubin ME, Warburton A, McBride AA (2024) Structure of the p53 degradation complex from HPV16. Nat Commun 15:1842. https:\/\/doi.org\/10.1038\/s41467-024-45920-w","journal-title":"Nat Commun"},{"key":"4722_CR87","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.24.291426","author":"World Health Organization","year":"2024","unstructured":"World Health Organization (2024) Cervical cancer prevention and control frameworks emphasize HPV vaccination, screening, and early intervention as core strategies for elimination. Bull World Health Organ. https:\/\/doi.org\/10.2471\/BLT.24.291426","journal-title":"Bull World Health Organ"},{"issue":"3","key":"4722_CR88","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.jncc.2024.11.006","volume":"5","author":"J Wu","year":"2025","unstructured":"Wu J, Jin Q, Zhang Y, Ji Y, Li J, Liu X, Duan H, Feng Z, Liu Y, Zhang Y, Lyu Z, Yang L, Huang Y (2025) Global burden of cervical cancer: current estimates, temporal trend and future projections based on the GLOBOCAN 2022. J Natl Cancer Inst 5(3):322\u2013329. https:\/\/doi.org\/10.1016\/j.jncc.2024.11.006","journal-title":"J Natl Cancer Inst"},{"key":"4722_CR89","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01349","volume":"11","author":"HH Xu","year":"2020","unstructured":"Xu HH, Yan WH, Lin A (2020) The role of HLA-G in human papillomavirus infections and cervical carcinogenesis. Front Immunol 11:1349. https:\/\/doi.org\/10.3389\/fimmu.2020.01349","journal-title":"Front Immunol"},{"issue":"3","key":"4722_CR90","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s00404-016-4037-6","volume":"294","author":"K Yi","year":"2016","unstructured":"Yi K, Yang L, Lan Z, Xi M (2016) The association between MTHFR polymorphisms and cervical cancer risk: a systematic review and meta-analysis. Arch Gynecol Obstet 294(3):579\u2013588. https:\/\/doi.org\/10.1007\/s00404-016-4037-6","journal-title":"Arch Gynecol Obstet"},{"key":"4722_CR91","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53830-0","volume":"15","author":"J Yu","year":"2024","unstructured":"Yu J, Gui X, Zou Y, Liu Q, Yang Z, An J, Guo X, Wang K, Guo J, Huang M, Zhou S, Zuo J, Chen Y, Deng L, Yuan G, Li N, Song Y, Jia J, Zeng J, Zhao Y, Liu X, Du X, Liu Y, Wang P, Zhang B, Ding L, Robles AI, Rodriguez H, Zhou H, Shao Z, Wu L, Gao D (2024) A proteogenomic analysis of cervical cancer reveals therapeutic and biological insights. Nat Commun 15:10114. https:\/\/doi.org\/10.1038\/s41467-024-53830-0","journal-title":"Nat Commun"},{"key":"4722_CR92","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53830-0","volume":"15","author":"J Yu","year":"2024","unstructured":"Yu J, An J, Huang M, Zuo J, Deng L, Yuan G, Li N, Song Y, Jia J, Zeng J, Zhao Y, Liu X, Gui X, Guo X, Zhou S, Wang K, Guo J, Chen Y, Ding L, Robles AI, Rodriguez H, Zhou H, Shao Z, Wu L, Gao D (2024) A proteogenomic analysis of cervical cancer reveals therapeutic and biological insights. Nat Commun 15:10114. https:\/\/doi.org\/10.1038\/s41467-024-53830-0","journal-title":"Nat Commun"},{"issue":"1","key":"4722_CR93","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1186\/s12967-023-04329-z","volume":"21","author":"SSF Yuan","year":"2023","unstructured":"Yuan SSF, Wang YM, Chan LP (2023) IL-1RA promotes oral squamous cell carcinoma malignancy through mitochondrial metabolism-mediated EGFR\/JNK\/SOX2 pathway. J Transl Med 21(1):473. https:\/\/doi.org\/10.1186\/s12967-023-04329-z","journal-title":"J Transl Med"},{"issue":"3","key":"4722_CR94","doi-asserted-by":"publisher","first-page":"815","DOI":"10.7314\/APJCP.2012.13.3.815","volume":"13","author":"ZY Zhang","year":"2012","unstructured":"Zhang ZY, Jin XY, Wu R, Wu LN, Xing R, Yang SJ, Xie Y (2012) Meta-analysis of the association between GSTM1 and GSTT1 gene polymorphisms and cervical cancer. Asian Pac J Cancer Prev 13(3):815\u2013819. https:\/\/doi.org\/10.7314\/APJCP.2012.13.3.815","journal-title":"Asian Pac J Cancer Prev"},{"issue":"6","key":"4722_CR95","doi-asserted-by":"publisher","first-page":"720","DOI":"10.21147\/j.issn.1000-9604.2020.06.05","volume":"32","author":"S Zhang","year":"2020","unstructured":"Zhang S, Xu H, Zhang L, Qiao Y (2020) Cervical cancer: epidemiology, risk factors and screening. Chin J Cancer Res 32(6):720\u2013728. https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2020.06.05","journal-title":"Chin J Cancer Res"},{"issue":"7","key":"4722_CR96","doi-asserted-by":"publisher","first-page":"547","DOI":"10.3390\/pathogens13070547","volume":"13","author":"Y Zheng","year":"2024","unstructured":"Zheng Y, Liu F, Wang Z (2024) HPV E6\/E7 oncoproteins drive carcinogenesis by promoting p53 ubiquitin-mediated degradation via E6-AP and dysregulation of the p16\/pRb\/E2F and p53 signaling pathways. Pathogens 13(7):547. https:\/\/doi.org\/10.3390\/pathogens13070547","journal-title":"Pathogens"}],"container-title":["Archives of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-026-04722-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00203-026-04722-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-026-04722-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T12:00:08Z","timestamp":1774699208000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00203-026-04722-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,16]]},"references-count":96,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["4722"],"URL":"https:\/\/doi.org\/10.1007\/s00203-026-04722-y","relation":{},"ISSN":["0302-8933","1432-072X"],"issn-type":[{"value":"0302-8933","type":"print"},{"value":"1432-072X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,16]]},"assertion":[{"value":"20 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"198"}}